Michael Morabito

Michael Morabito, Ph.D., is the Director of Investor Relations at Insmed Incorporated, leveraging extensive experience in corporate advisory and investor relations within the biopharma sector. They previously served as Managing Director at Solebury Strategic Communications and held positions at Credit Suisse and Chardan, focusing on equity research for biotech companies. They earned their Ph.D. in Neuroscience from Vanderbilt University and held roles in academic research, including as an Associate Research Scientist at Columbia University Medical Center. Michael has contributed to numerous publications and represented a diverse array of therapeutic areas throughout their career.